atenolol has been researched along with Asthma in 34 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigated the effects of an osmotic release oral drug delivery system of metoprolol on the changes induced by cumulative doses of inhaled salbutamol on bronchomotor tone, skeletal muscle, and the circulatory system after single (day 1) and multiple (day 7) dosing in 18 hypertensive asthmatic patients (forced expiratory volume in 1 second > 50% predicted; diastolic blood pressure > 90 mm Hg)." | 9.07 | Osmotic release oral drug delivery system of metoprolol in hypertensive asthmatic patients. Pharmacodynamic effects on beta 2-adrenergic receptors. ( Bauer, K; Kaik, B; Kaik, G, 1994) |
| " To study its cardioselectivity in humans, comparable beta-blocking doses of 200 mg ICI 141,292 and 100 mg atenolol were given to 12 patients with stable bronchial asthma." | 9.06 | Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma. ( Asted, M; Dirksen, H; Groth, S; Sørensen, PG; Tønnesen, P, 1986) |
| "The effects of single oral doses of atenolol 50 mg and xamoterol 200 mg (a recently developed partial beta 1-adrenoceptor agonist) on lung function, heart rate and blood pressure were investigated in 11 patients with asthma." | 9.06 | A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients. ( Folgering, HT; Lammers, JW; Müller, ME; van Herwaarden, CL, 1986) |
| "Seven asthmatic patients were given a single placebo tablet in a first test session and then in two subsequent double blind sessions they randomly received 400 mg bevantolol or 100 mg atenolol, with at least 2 days between each of the sessions." | 9.06 | Comparative study of the respiratory effects of two beta 1-selective blocking agents atenolol and bevantolol in asthmatic patients. ( Arnaud, A; Bruguerolle, B; Philip-Joet, F; Saadjian, A, 1986) |
| "The beta 2-adrenoceptor mediated effects on ventilatory capacity, forced expiratory volume in one second (FEV1), forced ventilatory capacity (FVC), heart rate, and skeletal muscle tremor of a new controlled-release (CR) formulation of metoprolol, 100 mg and 200 mg, and of atenolol tablets, 100 mg, were studied in eight asthmatic patients." | 9.06 | Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline. ( Dahlöf, C; Löfdahl, CG; Olofsson, B; Svedmyr, N; Westergren, G, 1988) |
| "The effects of two cardioselective beta-adrenergic blocking agents--celiprolol (claimed to have bronchodilator properties) and atenolol (without such claims)--on respiratory function and control of asthma were studied in ten asthmatic patients with mild to moderate essential hypertension." | 9.06 | Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. ( Bateman, ED; Jennings, AA; Opie, LH; van Zyl, AI, 1989) |
| "Sixteen normotensive asthmatic patients received single doses of 400 and 600 mg of celiprolol and 100 mg of atenolol in this placebo-controlled, double-blind crossover study." | 9.06 | Effects of high doses of celiprolol in asthmatic patients. ( Applin, WJ; Brown, R; Caruso, FS; Doshan, HD; Kapoor, M, 1986) |
| " In two, randomized, placebo-controlled, 5-way crossover trials, the pulmonary effects of celiprolol 200 and 400 mg, propranolol 40 mg and atenolol 100 mg were compared in 34 asthmatic patients." | 9.06 | Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. ( Applin, WJ; Brown, R; Caruso, FS; Doshan, HD; Rosenthal, RR; Slutsky, A, 1986) |
| "Eight asthmatic patients were investigated in a double-blind cross-over study after oral administration of 100 mg atenolol, 10 mg metoprolol and placebo." | 9.05 | Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients. ( Löfdahl, CG; Svedmyr, N, 1981) |
| "1 The effects of atenolol (100 mg), a cardioselective beta-adrenoceptor blocking agent, and labetalol (300 mg), a combined alpha- and non-selective beta-adrenoceptor blocking agent given in single doses were examined in a double-blind placebo controlled study in 11 asthmatic patients with hypertension." | 9.05 | Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma. ( Beevers, DG; Jackson, SH, 1983) |
| "The effects on ventilatory and cardiac function of atenolol, a new cardioselective beta-adrenoceptor blocking agent, were compared with those of practolol in a double-blind trial in 12 patients with asthma." | 9.04 | Effect of atenolol on ventilatory and cardiac function in asthma. ( Schaanning, J; Vilsvik, JS, 1976) |
| "In order to localize the main site of action of the beta 2-adrenoceptor selective agonist terbutaline and the beta 1-adrenoceptor selective antagonist atenolol in the airways of asthmatic patients, we compared the effects of these drugs on maximal expiratory flow-volume (MEFV) curves when breathing air and when breathing a helium-oxygen (HeO2) mixture." | 7.67 | Effects of terbutaline and atenolol on large and small airways in asthmatic patients. ( Folgering, HT; Lammers, JW; Müller, ME; van Herwaarden, CL, 1988) |
| "Fourteen patients with uncomplicated essential hypertension and mild asthma were treated with Atenolol 50-125 mg/day for up to 8 months." | 7.67 | Treatment of hypertension in mild asthmatic patients with atenolol. ( Clement, S; Grizotzki, B; Krauss, A; Krauss, S; Spitz, E, 1984) |
| "The effects of chronic cimetidine therapy on the pharmacodynamic properties of atenolol and metoprolol were assessed in eight asthmatic patients using a placebo-controlled trial." | 7.67 | The effect of cimetidine on the relative cardioselectivity of atenolol and metoprolol in asthmatic patients. ( Barker, NP; Ellis, ME; Fitzsimons, TJ; Hussain, M; Webb, AK, 1984) |
| "Twenty patients with severe or medium severe asthma were given atenolol (Atenol ICI-Pharma) and/or metoprolol (Seloken Hässle) for tachycardia, hyperkinetic tremor, arterial hypertension or symptoms of angina pectoris." | 7.66 | Comparison of the effect of the beta1-blocking drugs atenolol and metoprolol on bronchial asthma. ( Carlson, C; Järvinen, KA, 1978) |
| "Five patients with mild to moderate asthma were studied after an intravenous saline control followed by atenolol (i." | 7.65 | Comparison of the effects on airway conductance of a new selective beta-adrenergic blocking drug, atenolol, and propranolol in asthmatic subjects. ( Aström, H, 1975) |
| " A dose-response curve was then plotted after inhalation of the beta 2-adrenoceptor agonist terbutaline." | 6.66 | Ventilatory effects of atenolol and bevantolol in asthma. ( Folgering, HT; Lammers, JW; van Herwaarden, CL, 1985) |
| "This study investigated the effects of an osmotic release oral drug delivery system of metoprolol on the changes induced by cumulative doses of inhaled salbutamol on bronchomotor tone, skeletal muscle, and the circulatory system after single (day 1) and multiple (day 7) dosing in 18 hypertensive asthmatic patients (forced expiratory volume in 1 second > 50% predicted; diastolic blood pressure > 90 mm Hg)." | 5.07 | Osmotic release oral drug delivery system of metoprolol in hypertensive asthmatic patients. Pharmacodynamic effects on beta 2-adrenergic receptors. ( Bauer, K; Kaik, B; Kaik, G, 1994) |
| " To study its cardioselectivity in humans, comparable beta-blocking doses of 200 mg ICI 141,292 and 100 mg atenolol were given to 12 patients with stable bronchial asthma." | 5.06 | Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma. ( Asted, M; Dirksen, H; Groth, S; Sørensen, PG; Tønnesen, P, 1986) |
| " In two, randomized, placebo-controlled, 5-way crossover trials, the pulmonary effects of celiprolol 200 and 400 mg, propranolol 40 mg and atenolol 100 mg were compared in 34 asthmatic patients." | 5.06 | Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. ( Applin, WJ; Brown, R; Caruso, FS; Doshan, HD; Rosenthal, RR; Slutsky, A, 1986) |
| "Sixteen normotensive asthmatic patients received single doses of 400 and 600 mg of celiprolol and 100 mg of atenolol in this placebo-controlled, double-blind crossover study." | 5.06 | Effects of high doses of celiprolol in asthmatic patients. ( Applin, WJ; Brown, R; Caruso, FS; Doshan, HD; Kapoor, M, 1986) |
| "The effects of two cardioselective beta-adrenergic blocking agents--celiprolol (claimed to have bronchodilator properties) and atenolol (without such claims)--on respiratory function and control of asthma were studied in ten asthmatic patients with mild to moderate essential hypertension." | 5.06 | Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. ( Bateman, ED; Jennings, AA; Opie, LH; van Zyl, AI, 1989) |
| "The effects on baseline ventilation as well as beta 2-receptor stimulant-induced bronchodilation and tremor of atenolol and dilevalol, a beta-blocking agent with non-selective beta-antagonistic properties and intrinsic activity on the beta 2-receptor were evaluated in 8 patients with stable asthma." | 5.06 | Effects of dilevalol, a beta-adrenoceptor antagonist with intrinsic sympathetic activity in asthmatic patients. ( Hedner, J; Lemne, C; Svedmyr, N; Ullman, A, 1989) |
| "The beta 2-adrenoceptor mediated effects on ventilatory capacity, forced expiratory volume in one second (FEV1), forced ventilatory capacity (FVC), heart rate, and skeletal muscle tremor of a new controlled-release (CR) formulation of metoprolol, 100 mg and 200 mg, and of atenolol tablets, 100 mg, were studied in eight asthmatic patients." | 5.06 | Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline. ( Dahlöf, C; Löfdahl, CG; Olofsson, B; Svedmyr, N; Westergren, G, 1988) |
| "Seven asthmatic patients were given a single placebo tablet in a first test session and then in two subsequent double blind sessions they randomly received 400 mg bevantolol or 100 mg atenolol, with at least 2 days between each of the sessions." | 5.06 | Comparative study of the respiratory effects of two beta 1-selective blocking agents atenolol and bevantolol in asthmatic patients. ( Arnaud, A; Bruguerolle, B; Philip-Joet, F; Saadjian, A, 1986) |
| "The effects of single oral doses of atenolol 50 mg and xamoterol 200 mg (a recently developed partial beta 1-adrenoceptor agonist) on lung function, heart rate and blood pressure were investigated in 11 patients with asthma." | 5.06 | A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients. ( Folgering, HT; Lammers, JW; Müller, ME; van Herwaarden, CL, 1986) |
| " This study concerned 21 patients: 8 asthmatics and 13 spastic bronchitics, treated over a period of 4 months in a cross-over, double-blind test by 2 cardio-selective beta-blockers (2 months: betaxolol, 2 months atenolol)." | 5.06 | [Long-term beta adrenergic antagonists in spastic bronchopathies]. ( Blaive, B; Lemoigne, F; Lewest, G; Nahon, F, 1988) |
| "Eight asthmatic patients were investigated in a double-blind cross-over study after oral administration of 100 mg atenolol, 10 mg metoprolol and placebo." | 5.05 | Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients. ( Löfdahl, CG; Svedmyr, N, 1981) |
| "1 The effects of atenolol (100 mg), a cardioselective beta-adrenoceptor blocking agent, and labetalol (300 mg), a combined alpha- and non-selective beta-adrenoceptor blocking agent given in single doses were examined in a double-blind placebo controlled study in 11 asthmatic patients with hypertension." | 5.05 | Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma. ( Beevers, DG; Jackson, SH, 1983) |
| "In a randomized, blind crossover study in 14 hypertensive patients with asthma, involving placebo and chronically administered (3 weeks) equipotent beta1-blocking doses of atenolol 100 mg once daily and metoprolol 100 mg bid, atenolol and metoprolol produced a similar fall in blood pressure." | 5.05 | Asthma and beta-blockers. ( Chatterjee, SS; Cruickshank, JM; Lawrence, DS; Sahay, JN, 1982) |
| "The effects on ventilatory and cardiac function of atenolol, a new cardioselective beta-adrenoceptor blocking agent, were compared with those of practolol in a double-blind trial in 12 patients with asthma." | 5.04 | Effect of atenolol on ventilatory and cardiac function in asthma. ( Schaanning, J; Vilsvik, JS, 1976) |
| "The effects of chronic cimetidine therapy on the pharmacodynamic properties of atenolol and metoprolol were assessed in eight asthmatic patients using a placebo-controlled trial." | 3.67 | The effect of cimetidine on the relative cardioselectivity of atenolol and metoprolol in asthmatic patients. ( Barker, NP; Ellis, ME; Fitzsimons, TJ; Hussain, M; Webb, AK, 1984) |
| "In order to localize the main site of action of the beta 2-adrenoceptor selective agonist terbutaline and the beta 1-adrenoceptor selective antagonist atenolol in the airways of asthmatic patients, we compared the effects of these drugs on maximal expiratory flow-volume (MEFV) curves when breathing air and when breathing a helium-oxygen (HeO2) mixture." | 3.67 | Effects of terbutaline and atenolol on large and small airways in asthmatic patients. ( Folgering, HT; Lammers, JW; Müller, ME; van Herwaarden, CL, 1988) |
| "Fourteen patients with uncomplicated essential hypertension and mild asthma were treated with Atenolol 50-125 mg/day for up to 8 months." | 3.67 | Treatment of hypertension in mild asthmatic patients with atenolol. ( Clement, S; Grizotzki, B; Krauss, A; Krauss, S; Spitz, E, 1984) |
| "Twenty patients with severe or medium severe asthma were given atenolol (Atenol ICI-Pharma) and/or metoprolol (Seloken Hässle) for tachycardia, hyperkinetic tremor, arterial hypertension or symptoms of angina pectoris." | 3.66 | Comparison of the effect of the beta1-blocking drugs atenolol and metoprolol on bronchial asthma. ( Carlson, C; Järvinen, KA, 1978) |
| "Five patients with mild to moderate asthma were studied after an intravenous saline control followed by atenolol (i." | 3.65 | Comparison of the effects on airway conductance of a new selective beta-adrenergic blocking drug, atenolol, and propranolol in asthmatic subjects. ( Aström, H, 1975) |
| " A dose-response curve was then plotted after inhalation of the beta 2-adrenoceptor agonist terbutaline." | 2.66 | Ventilatory effects of atenolol and bevantolol in asthma. ( Folgering, HT; Lammers, JW; van Herwaarden, CL, 1985) |
| "6 Atenolol 60 mg was the only drug to allow a fenoterol airway response similar to placebo." | 2.65 | Assessment of beta-adrenoceptor antagonists in asthmatic patients. ( Alpers, JH; Crockett, AJ; Latimer, KM; McIntyre, EL; Ruffin, RE; Ward, HE, 1982) |
| "Metoprolol and atenolol were generally well tolerated except at higher doses such as metoprolol >100 mg daily." | 1.38 | Cardioselective beta-blocker treatment of hypertension in patients with asthma: when do benefits outweigh risks? ( Self, TH; Soberman, JE; Wallace, JL, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (85.29) | 18.7374 |
| 1990's | 4 (11.76) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (2.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Self, TH | 1 |
| Wallace, JL | 1 |
| Soberman, JE | 1 |
| Greefhorst, AP | 1 |
| van Herwaarden, CL | 4 |
| Ruffin, RE | 1 |
| McIntyre, EL | 1 |
| Latimer, KM | 1 |
| Ward, HE | 1 |
| Crockett, AJ | 1 |
| Alpers, JH | 1 |
| Löfdahl, CG | 3 |
| Lawrence, DS | 1 |
| Sahay, JN | 2 |
| Chatterjee, SS | 2 |
| Cruickshank, JM | 2 |
| Krauss, S | 1 |
| Spitz, E | 1 |
| Krauss, A | 1 |
| Grizotzki, B | 1 |
| Clement, S | 1 |
| Ellis, ME | 2 |
| Hussain, M | 1 |
| Webb, AK | 1 |
| Barker, NP | 1 |
| Fitzsimons, TJ | 1 |
| Svedmyr, N | 3 |
| Jackson, SH | 1 |
| Beevers, DG | 1 |
| Chazan, R | 2 |
| Droszcz, W | 1 |
| Doboszyńska, A | 1 |
| Kowalski, J | 1 |
| Barliński, J | 1 |
| Ellis, SH | 1 |
| Gale, AE | 1 |
| Bauer, K | 1 |
| Kaik, G | 1 |
| Kaik, B | 1 |
| Szmidt, M | 1 |
| Minc, P | 1 |
| Wasiak, W | 1 |
| Vilsvik, JS | 2 |
| Schaanning, J | 2 |
| Hugues, FC | 1 |
| Julien, D | 1 |
| Munera, Y | 1 |
| Marche, J | 1 |
| Boye, NP | 1 |
| Vale, JR | 1 |
| Hellström, PE | 1 |
| Salonen, T | 1 |
| Carlson, C | 1 |
| Järvinen, KA | 1 |
| Aström, H | 1 |
| Doshan, HD | 2 |
| Rosenthal, RR | 1 |
| Brown, R | 2 |
| Slutsky, A | 1 |
| Applin, WJ | 2 |
| Caruso, FS | 2 |
| Kapoor, M | 1 |
| van Zyl, AI | 1 |
| Jennings, AA | 1 |
| Bateman, ED | 1 |
| Opie, LH | 1 |
| Hedner, J | 1 |
| Ullman, A | 1 |
| Lemne, C | 1 |
| Dahlöf, C | 1 |
| Westergren, G | 1 |
| Olofsson, B | 1 |
| Philip-Joet, F | 1 |
| Saadjian, A | 1 |
| Bruguerolle, B | 1 |
| Arnaud, A | 1 |
| Lammers, JW | 3 |
| Müller, ME | 2 |
| Folgering, HT | 3 |
| Blaive, B | 1 |
| Nahon, F | 1 |
| Lemoigne, F | 1 |
| Lewest, G | 1 |
| Groth, S | 1 |
| Tønnesen, P | 1 |
| Asted, M | 1 |
| Dirksen, H | 1 |
| Sørensen, PG | 1 |
| Górecka, D | 1 |
| Chodosowska, E | 1 |
| Grebska, E | 1 |
1 review available for atenolol and Asthma
| Article | Year |
|---|---|
[Atenolol in the treatment of patients with airway obstruction].
Topics: Adrenergic beta-Antagonists; Airway Obstruction; Airway Resistance; Animals; Arrhythmias, Cardiac; A | 1998 |
24 trials available for atenolol and Asthma
| Article | Year |
|---|---|
Comparative study of the ventilatory effects of three beta 1-selective blocking agents in asthmatic patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Bronchi; Clinical Trials as Topic; | 1981 |
Assessment of beta-adrenoceptor antagonists in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Female; Forced Expiratory Volume; Humans; Male | 1982 |
Selectivity of beta-adrenoceptor agonists and antagonists in asthmatics.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Asthma; Atenolol; Blood Pressure; Cl | 1982 |
Asthma and beta-blockers.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Clinical Trials as Topic; Double-B | 1982 |
Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients.
Topics: Adult; Aged; Asthma; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female | 1981 |
Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma.
Topics: Adult; Asthma; Atenolol; Blood Pressure; Ethanolamines; Female; Forced Expiratory Volume; Humans; Hy | 1983 |
Cardioselectivity of atenolol in asthmatic patients.
Topics: Airway Resistance; Asthma; Atenolol; Clinical Trials as Topic; Double-Blind Method; Forced Expirator | 1981 |
Osmotic release oral drug delivery system of metoprolol in hypertensive asthmatic patients. Pharmacodynamic effects on beta 2-adrenergic receptors.
Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Adult; Albuterol; Asthma; Atenolol; Double- | 1994 |
[Comparison of the influence of celiprolol, metoprolol and atenolol on pulmonary ventilation in patients with asthma].
Topics: Adrenergic beta-Antagonists; Adult; Area Under Curve; Asthma; Atenolol; Celiprolol; Female; Hemodyna | 1999 |
Effect of atenolol on ventilatory and cardiac function in asthma.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Blood Pressure; Cardiac Output; Clinical Trial | 1976 |
[Study of the respiratory tolerance of adrenolytic beta-blockers in the asthmatic].
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Bronchial Spasm; Female; Forced Expiratory Vol | 1978 |
Effect in bronchial asthma of a new beta-adrenergic blocking drug atenolol (ICI 66, 082).
Topics: Adult; Aged; Albuterol; Asthma; Atenolol; Clinical Trials as Topic; Drug Interactions; Female; Human | 1977 |
Effect of atenolol on cardiac and ventilatory function in patients with chronic asthma.
Topics: Asthma; Atenolol; Clinical Trials as Topic; Double-Blind Method; Hemodynamics; Humans; Physical Exer | 1977 |
[Therapeutic differences between atenolol and pindolol in asthmatic patients].
Topics: Asthma; Atenolol; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Hemodynamics; Huma | 1979 |
Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Asthma; Atenolol; Celiprolol; Forced Expiratory Volume; Humans; Hyperte | 1986 |
Effects of high doses of celiprolol in asthmatic patients.
Topics: Adult; Asthma; Atenolol; Bronchi; Celiprolol; Double-Blind Method; Forced Expiratory Volume; Humans; | 1986 |
Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Asthma; Atenolol; Blood Pressure; Celip | 1989 |
Effects of dilevalol, a beta-adrenoceptor antagonist with intrinsic sympathetic activity in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Asthma; Atenolol; Double-Blind Method; Female; Forced Expi | 1989 |
Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.
Topics: Adult; Aged; Asthma; Atenolol; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind M | 1988 |
Comparative study of the respiratory effects of two beta 1-selective blocking agents atenolol and bevantolol in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Clinical Trials as Topic; Double-Blind Method; | 1986 |
A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
Topics: Adrenergic beta-Agonists; Adult; Asthma; Atenolol; Blood Pressure; Double-Blind Method; Forced Expir | 1986 |
[Long-term beta adrenergic antagonists in spastic bronchopathies].
Topics: Adrenergic beta-Antagonists; Asthma; Atenolol; Betaxolol; Bronchitis; Drug Evaluation; Drug Toleranc | 1988 |
Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma.
Topics: Adult; Aged; Asthma; Atenolol; Benzeneacetamides; Blood Pressure; Clinical Trials as Topic; Double-B | 1986 |
Ventilatory effects of atenolol and bevantolol in asthma.
Topics: Administration, Oral; Adult; Asthma; Atenolol; Blood Pressure; Chromatography, High Pressure Liquid; | 1985 |
9 other studies available for atenolol and Asthma
| Article | Year |
|---|---|
Cardioselective beta-blocker treatment of hypertension in patients with asthma: when do benefits outweigh risks?
Topics: Adrenergic beta-1 Receptor Antagonists; Asthma; Atenolol; Dose-Response Relationship, Drug; Humans; | 2012 |
Treatment of hypertension in mild asthmatic patients with atenolol.
Topics: Adult; Albuterol; Asthma; Atenolol; Blood Pressure; Electrocardiography; Exercise Test; Female; Hear | 1984 |
The effect of cimetidine on the relative cardioselectivity of atenolol and metoprolol in asthmatic patients.
Topics: Asthma; Atenolol; Cimetidine; Double-Blind Method; Drug Interactions; Forced Expiratory Volume; Hear | 1984 |
[Usefulness of atenolol in the treatment of patients with chronic bronchitis or bronchial asthma].
Topics: Adult; Aged; Asthma; Atenolol; Blood Pressure; Bronchitis; Chronic Disease; Depression, Chemical; Fe | 1983 |
Beta-blockers and asthma.
Topics: Asthma; Atenolol; Contraindications; Humans | 1995 |
Comparison of the effect of the beta1-blocking drugs atenolol and metoprolol on bronchial asthma.
Topics: Adult; Aged; Asthma; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Male; Metoprolol; Middle | 1978 |
Comparison of the effects on airway conductance of a new selective beta-adrenergic blocking drug, atenolol, and propranolol in asthmatic subjects.
Topics: Aged; Airway Resistance; Asthma; Atenolol; Drug Evaluation; Female; Heart Rate; Humans; Male; Middle | 1975 |
Effects of terbutaline and atenolol on large and small airways in asthmatic patients.
Topics: Administration, Inhalation; Adult; Airway Resistance; Asthma; Atenolol; Dose-Response Relationship, | 1988 |
[Effect of atenolol on bronchial patency in patients with diffuse bronchial stenosis].
Topics: Adult; Aged; Arrhythmias, Cardiac; Asthma; Atenolol; Bronchial Spasm; Bronchitis; Female; Humans; Ma | 1985 |